Steven Oliveira

Präsident bei Oliveira Capital LLC

Vermögen: 343 569 $ am 31.05.2024

56 Jahre

Health Technology

Consumer Durables

Miscellaneous

Aktive Positionen von Steven Oliveira

Unternehmen	Position	Beginn	Ende
Oliveira Capital LLC	Präsident	01.01.2002	-

Unternehmen	Position	Beginn	Ende
Chardan SPAC Asset Management LLC	Chief Investment Officer	01.01.2008	01.01.2013
IDEANOMICS, INC.	Direktor/Vorstandsmitglied	30.11.2010	30.03.2011
REPROS THERAPEUTICS INC	Direktor/Vorstandsmitglied	11.10.2011	-
SIGA TECHNOLOGIES, INC.	Gründer	01.01.1995	-
CSO Ventures	Corporate Officer/Principal	01.01.1995	-
Assertio Therapeutics, Inc. Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.	Gründer	-	-
Pulte Acquisition Corp. Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL.	Direktor/Vorstandsmitglied	30.07.2015	-
	Independent Dir/Board Member	30.07.2015	-

Manhattan College

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	3
Founder	2
Independent Dir/Board Member	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
IDEANOMICS, INC.	Consumer Durables
SIGA TECHNOLOGIES, INC.	Health Technology

Private Unternehmen	6
Pulte Acquisition Corp. Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL.	Miscellaneous
Oliveira Capital LLC
Chardan SPAC Asset Management LLC
Assertio Therapeutics, Inc. Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.	Health Technology
CSO Ventures
Repros Therapeutics, Inc. Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX.	Health Technology